Jim Cramer: Hope for the Best, Plan for the Worst

Is this the end of the world? No. You still need to plan for your financial well-being, even as the CDC tells us 'this might be bad.'

The Charts of Johnson & Johnson Show What It's Made Of

The company has grown organically and by acquisitions. It has dealt with adversity and bad news.

If You Invest in Small-Cap Stocks, You've Got to Learn to Deal With Setbacks

Tivity Health's big price drop serves as an example of the thought process an investor must go through when a holding takes an unexpected hit.

Jim Cramer: Let's Put the Coronavirus Risk Into Proper Perspective, Shall We?

The ultimate economic impact of the disease isn't clear, but what is clear is who is most at risk and where you're mostly likely to contract it.

Bausch Health Looks a Little Blurry Ahead of Earnings

Let's check out the charts of this Canada-based company.

Jim Cramer: Know How to Invest Amid Coronavirus, but Don't Forget its Victims

The human cost of the virus is real, so don't overlook that, but also know the companies who are in a position to benefit.

Colgate-Palmolive Gets Its Groove Back, Could Rise 20% From Here

Look for CL to see higher prices after some consolidative price action.

3 Charts That Are Setting Up as Buy Opportunities

KLA Corp. and Target already have triggered entry points, while CVS Health soon could.

Jim Cramer: We're Getting Spun in a Crazy, Virtuous Circle

This market's bound by earnings and a virus, and both are astonishingly subjective.

Agilent Technologies Passes This Acid Test

A appears set to trade higher in the coming weeks, according to the charts and indicators.